ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2014 Results

PR Newswire

SAN DIEGO, March 25, 2014 /PRNewswire/ -- RESMED INC. (RMD) announced today that on Wednesday, April 23, 2014, it will release its results for the third quarter and nine months of fiscal year 2014, ended March 31, 2014. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

View photo

.
ResMed Inc. logo

The conference call is scheduled to begin at 1:30 p.m. US Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com.  Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q3 2014 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:

9:30 p.m. 

London

6:30 a.m.  

Sydney, Australia (April 24, 2014)

TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:

US:                         

847-585-4405

Outside US:              

+1 847-585-4405    

Conference Name:        

Q3 2014 ResMed Inc. Results Conference Call 

Participant Passcode:    

36956405

The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

US:                     

630- 652-3042  

Outside US:          

+1 630-652-3042  

Passcode:             

36956405

ResMed is a global leader in the development, manufacturing, and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.
Further information can be obtained by contacting David Pendarivs at ResMed Inc. at +1 (858) 836-5983, or by visiting the company's website at www.resmed.com.

Logo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a

 

 

Rates

View Comments (0)